Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) dipped 0.5% to $3.82 after the company disclosed that the USPTO has granted composition of matter patent to company for small molecule complement alternative pathway factor D inhibitors. Share volume was 471,000, compared to an all-day average of 1.4 million
